News

TB Alliance, a not-for-profit organization with the mission of developing better, faster-acting, and affordable TB treatments, announces the election to […]

TB Alliance announces new leadership of its Stakeholders Association (SHA), an advisory group comprised of member organizations that share a

The phase 2b clinical trial of the TB vaccine candidate MVA85A is historic, the first efficacy study of a novel

Pyrazinamide (PZA) is an incredibly important sterilizing agent in the treatment of tuberculosis and is considered responsible for reducing the

The US FDA approval of bedaquiline is historic, as it marks the first drug in a new class approved to

Tuberculosis (TB) is a major cause of illness and death among children in low- and middle-income countries, but the current

Even though it’s preventable and treatable, tuberculosis (TB) is a top ten killer of children worldwide. Today, the ACTION Partnership

NEW YORK, NY/GENEVA, SWITZERLAND – A new partnership announced today will increase efforts to coordinate the development of complementary novel